Capsule endoscopy developer Given Imaging (Nasdaq: GIVN; TASE:GIVN) today announced that the UK National Health Service (NHS) has issued guidance on the use of capsule endoscopy for detecting small bowel disorders. According to the guidance issued by the National Institute for Clinical Excellence (NICE), all UK residents now have access to capsule endoscopy for obscure GI bleeding, the investigation and diagnosis of Crohn's disease, and other indications.
Given Imaging president and CEO Gavriel D. Meron stated, "We applaud the UK government's decision. Approval in the United Kingdom means that 58 million UK residents now have free access to capsule endoscopy under the NHS public health system."
Given Imaging is developing a complete line of PillCam video capsules for detecting disorders throughout the gastrointestinal tract. The company's technology platform features the PillCam, a disposable miniature video camera contained in a capsule, which is ingested by the patient.
The PillCam SB provides direct visualization of the entire small intestine. It is currently marketed in the US and in more than 60 other countries. The PillCam ESO provides visual examination of the esophagus, has been cleared for marketing by the FDA. Additional capsules for visualization of the stomach and colon are under development.
Given Imaging's headquarters, manufacturing and R&D facilities are located in Yokneam.
Published by Globes [online], Israel business news - www.globes.co.il - on Thursday, December 16, 2004